NCT06003816 Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)
| NCT ID | NCT06003816 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins Bloomberg School of Public Health |
| Condition | Cholera |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,140 participants |
| Start Date | 2023-10-18 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,140 participants in total. It began in 2023-10-18 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Objective: The investigators objective is to develop and evaluate the effectiveness of a case area targeted water, sanitation, and hygiene (WASH) intervention in reducing cholera infections and increasing sustained WASH behaviors in transmission hotspots in a ring around cholera cases.
Eligibility Criteria
Inclusion Criteria: * Index cholera patient have no running water inside of their home Exclusion Criteria: * No one will be excluded because of age, sex, religion, or sexual preference
Contact & Investigator
Christine Marie George, PhD
PRINCIPAL INVESTIGATOR
Johns Hopkins Bloomberg School of Public Health
Frequently Asked Questions
Who can join the NCT06003816 clinical trial?
This trial is open to participants of all sexes, studying Cholera. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06003816 currently recruiting?
Yes, NCT06003816 is actively recruiting participants. Contact the research team at cmgeorge@jhu.edu for enrollment information.
Where is the NCT06003816 trial being conducted?
This trial is being conducted at Dhaka, Bangladesh, Dhaka, Bangladesh.
Who is sponsoring the NCT06003816 clinical trial?
NCT06003816 is sponsored by Johns Hopkins Bloomberg School of Public Health. The principal investigator is Christine Marie George, PhD at Johns Hopkins Bloomberg School of Public Health. The trial plans to enroll 3,140 participants.